Application 074203
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ATENOLOL AND CHLORTHALIDONE | ATENOLOL; CHLORTHALIDONE | TABLET;ORAL | 50MG;25MG | No | No |
| 002 | ATENOLOL AND CHLORTHALIDONE | ATENOLOL; CHLORTHALIDONE | TABLET;ORAL | 100MG;25MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A074203-001 | ATENOLOL AND CHLORTHALIDONE | ATENOLOL; CHLORTHALIDONE | 50MG;25MG | TABLET / ORAL | 1993-10-31 | ||
| A074203-002 | ATENOLOL AND CHLORTHALIDONE | ATENOLOL; CHLORTHALIDONE | 100MG;25MG | TABLET / ORAL | 1993-10-31 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A074203-001 | ATENOLOL AND CHLORTHALIDONE | 50MG;25MG | TABLET / ORAL | 1993-10-31 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A074203-002 | ATENOLOL AND CHLORTHALIDONE | 100MG;25MG | TABLET / ORAL | 1993-10-31 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A074203-001 | ATENOLOL AND CHLORTHALIDONE | 50MG;25MG | TABLET / ORAL | 1993-10-31 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A074203-002 | ATENOLOL AND CHLORTHALIDONE | 100MG;25MG | TABLET / ORAL | 1993-10-31 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A074203-001 | ATENOLOL AND CHLORTHALIDONE | 50MG;25MG | TABLET / ORAL | 1993-10-31 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A074203-002 | ATENOLOL AND CHLORTHALIDONE | 100MG;25MG | TABLET / ORAL | 1993-10-31 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A074203-001 | ATENOLOL AND CHLORTHALIDONE | 50MG;25MG | TABLET / ORAL | 1993-10-31 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A074203-002 | ATENOLOL AND CHLORTHALIDONE | 100MG;25MG | TABLET / ORAL | 1993-10-31 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A074203-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A074203-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A074203-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A074203-002 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A074203-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A074203-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A074203-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A074203-002 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atenolol and Chlorthalidone | ATENOLOL AND CHLORTHALIDONE | REMEDYREPACK INC. | dfbd0160-f56a-41b9-a4ff-eb2df73b1e9b | 2026-08-27 | Warnings, Adverse reactions | Atenolol and Chlorthalidone |
| Atenolol and Chlorthalidone | ATENOLOL AND CHLORTHALIDONE | Preferred Pharmaceuticals Inc. | c58e12ad-d705-4643-91ac-ff079e9eb28e | 2026-07-16 | Warnings, Adverse reactions | Atenolol and Chlorthalidone |
| Atenolol and Chlorthalidone | ATENOLOL AND CHLORTHALIDONE | PD-Rx Pharmaceuticals, Inc. | 78b374f8-0e16-4c15-85c1-16609ac3aca2 | 2025-10-20 | Warnings, Adverse reactions | Atenolol and Chlorthalidone |
| ATENOLOL AND CHLORTHALIDONE | ATENOLOL AND CHLORTHALIDONE TABLET | MARLEX PHARMACEUTICALS, INC | db22ff31-52f6-9024-e053-2995a90af8b3 | 2025-09-22 | Warnings, Adverse reactions | ATENOLOL AND CHLORTHALIDONE |
| Atenolol and Chlorthalidone | ATENOLOL AND CHLORTHALIDONE | ANI Pharmaceuticals, Inc. | 33690cc7-fffc-4620-888d-7f6453fe58c1 | 2024-03-14 | Warnings, Adverse reactions | Atenolol and Chlorthalidone |
| Atenolol and Chlorthalidone | ATENOLOL AND CHLORTHALIDONE | Actavis Pharma, Inc. | a6794dfa-adbb-491b-9d48-f89a44e866c5 | 2024-03-01 | Warnings, Adverse reactions | Atenolol and Chlorthalidone |
| Atenolol and Chlorthalidone | ATENOLOL AND CHLORTHALIDONE | Unichem Pharmaceuticals (USA), Inc. | a85d28c1-e812-4c12-aa67-136bff3610e5 | 2024-01-16 | Warnings, Adverse reactions | Atenolol and Chlorthalidone |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-2063 | Atenolol and Chlorthalidone | atenolol and chlorthalidone | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-2064 | Atenolol and Chlorthalidone | atenolol and chlorthalidone | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 43353-985 | Atenolol and Chlorthalidone | atenolol and chlorthalidone | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |